Paradoxically, from our transcriptomic analysis of human LUAD, we found that LAIR2 expression was associated with adverse patient outcomes and signatures of negative immune regulation rather than conditions associated with favorable tumor immunity. This evidence concerns the gene LAIR2 and neoplasm.